AB Science SA (Over The Counter Market:ABSCF)
| 10.60 Delayed Data As of Jun 03 |  0.00 / 0.00%Today’s Change | 9.60 Today|||52-Week Range 18.78 | -- Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -29.6M | -30.6M | -30.6M | -30.7M | |
| Depreciation | 434.7K | 675.9K | 491.8K | 789.3K | ||
| Total Other Cash Flow | -476.8K | -2.0M | -1.4M | -2.9M | ||
| Funds From Operations | -29.7M | -32.0M | -31.5M | -32.8M | ||
| Funds From/For Other Operating Expenses | -3.9M | 5.2M | -5.7M | -1.2M | ||
| Net Cash Flow - Operating Activities | -25.8M | -37.2M | -25.8M | -31.6M | ||
| Investing | Increase In Investments | -6.7M | 0.00 | 0.00 | 0.00 | |
| Decrease In Investments | 6.6M | 6.6M | 0.00 | 0.00 | ||
| Capital Expenditures | -97.6K | -76.3K | -511.0K | -488.4K | ||
| Net Cash Flow Investing | -706.4K | 6.1M | -567.4K | -571.0K | ||
| Financing | Short Term Borrowings | -- | -- | 0.00 | -- | -- |
| Long Term Borrowings | 3.7M | 0.00 | 0.00 | -- | ||
| Long Term Debt Reduction | -633.2K | -158.2K | 0.00 | -- | ||
| Net Proceeds Stock Sale | 26.2M | 35.8M | 47.8M | 72.0K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 29.3M | 35.7M | 47.8M | 72.0K | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -53.2K | -8.8K | 32.7K | -8.3K | |
| Net Change In Cash | 2.8M | 4.5M | 21.4M | -32.1M | ||
